Saturday July 4 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Acorn Cardiovascular

Acorn Cardiovascular™ is a privately held medical device company that was incorporated in 1996 and is located in St. Paul, Minnesota, USA. Mission: Acorn Cardiovascular develops innovative solutions to successfully treat patients with heart failure and restore hope for a better, longer life. Background: Heart failure (HF) is a condition that is caused by damage to the heart muscle, which results in the inability of the heart to pump enough blood to meet the needs of the body. This highly debilitating and progressive disorder affects more than five million people in the United States and 25 million people worldwide. An estimated 550,000 new HF cases are diagnosed each year in the United States alone. Heart failure can be caused by or is the end result of a number of conditions, including coronary artery disease, prolonged high blood pressure, poor valve function or other cardiovascular abnormalities. CorCap™ Cardiac Support Device (CSD): The company’s introductory product, the CorCap™ Cardiac Support Device (CSD), is proprietary mesh wrap that is placed around the heart to provide gentle, permanent support. It is intended to prevent and reverse the progression of heart failure by improving the heart’s structure and function, leading to improvements in the quality of a patient’s life. The CorCap CSD received CE marking in September 2000. Randomized clinical trials evaluating effectiveness of the CorCap CSD have been completed in North America and Europe. The CorCap CSD has been used in the treatment of more than 460 patients worldwide.


Contact Details:
601 Campus Drive
St. Paul,
Minnesota
55112
United States of America
Tel:651-286-4800
Fax:651-286-4848
Email:info@acorncv.com
WWW:

www.acorncv.com/




Loading...

Recent Publications by Acorn Cardiovascular:

Design and features of the Acorn CorCap Cardiac Support Device: the concept of passive mechanical diastolic support.
The Laplace equation points to the importance of ventricular wall stress...
17th March, 2006
Acorn Cardiovascular, Inc., 651 Campus Drive, St. Paul, MN 55112, USA. Heart Fail Rev. 2005 Jun;10(2):101-7.
DOI Direct Link
Development and validation of a patient questionnaire to determine New York Heart Association classification.
BACKGROUND: New York Heart Association (NYHA) classification correlates...
17th December, 2004
Acorn Cardiovascular Inc., St. Paul, Minnesota 55112, USA. J Card Fail. 2004 Jun;10(3):228-35.

Acorn Cardiovascular Patents:

US Patent No.Title
6169922 Defibrillating cardiac jacket with interwoven electrode grids
6567699 Defibrillating cardiac constraint
6572533 Cardiac disease treatment and device
6575921 Device for heart measurement
6579226 Delivery of cardiac constraint jacket

View more Acorn Cardiovascular patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 401 times since April 2007, the link to the organisation's website has been followed 78 times

Recent Search Terms used to find this page: acorn cardiovascular | unite acorn medical devices | acorncv.com | Acorn CorCap videos | ACORN CORCAP | acorn Medical functions | acorn cardiovascular | acorn corcap 2009 | t | Acorn cardiovascular clinical trial results | .

Search for more companies in St. Paul,

Search for more companies in Minnesota



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Acorn Cardiovascular

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.